Related Experiment Video
Updated: Sep 2, 2025

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Enteral Calcium or Phosphorus Supplementation in Preterm or Low Birth Weight Infants: a Systematic Review and
Mohan Kumar1, Ranadip Chowdhury1,2, Bireshwar Sinha1,2
1Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.
Insights
Enteral supplementation with calcium or phosphorus in human milk-fed preterm infants showed a reduction in osteopenia. However, evidence is insufficient to determine overall benefits or harms for these vulnerable infants.
Area of Science:
- Neonatal Nutrition
- Pediatric Gastroenterology
- Clinical Nutrition
Background:
- Preterm and low birth weight infants fed human milk are at risk for mineral deficiencies.
- Osteopenia is a common complication in these infants, impacting bone health.
- Supplementation with calcium and phosphorus is a common practice to address these deficiencies.
Purpose of the Study:
- To assess the effects of calcium or phosphorus supplementation versus no supplementation in human milk-fed preterm or low birth weight infants.
- To evaluate the impact of supplementation on osteopenia, growth parameters, and biochemical markers.
- To synthesize evidence from available randomized and non-randomized controlled trials.
Main Methods:
- Searched major databases (Cochrane, Medline, Embase) for relevant trials.
- Included randomized controlled trials (RCTs) and quasi-randomized trials.
- Analyzed data from three studies involving 162 infants.
Main Results:
- A reduction in osteopenia was observed at 38 weeks (RR 0.68, 95% CI 0.46-0.99).
- No significant effects were found on weight, length, or head circumference at 6 weeks.
- No significant effects were noted on alkaline phosphatase, serum calcium, or serum phosphorus levels.
- The certainty of evidence was rated as very low to low.
Conclusions:
- Current evidence is insufficient to determine the benefits or harms of enteral calcium or phosphorus supplementation in human milk-fed preterm infants.
- Further high-quality research is needed to establish optimal supplementation strategies.
- The findings highlight the need for careful consideration of supplementation in this population.
Objectives:
To assess effects of calcium or phosphorous supplementation compared with no supplementation in human milk-fed preterm or low birth weight infants.
Methods:
Data sources include Cochrane Central Register of Controlled Trials, Medline and Embase. We included Randomized controlled trials (RCTs) and non-randomized trials (quasi-randomized).
Results:
Three studies (4 reports; 162 infants) were included. At latest follow-up (38 weeks), there was reduction in osteopenia (3 studies, 159 participants, relative risk 0.68, 95% confidence interval [CI] 0.46-0.99). At latest follow-up (6 weeks), there was no effect on weight (1 study, 40 participants, mean difference [MD] 138.50 g, 95% CI -82.16 to 359.16); length (1 study, 40 participants, MD 0.77 cm, 95% CI -0.93 to 2.47); and head circumference (1 study, 40 participants, MD 0.33 cm, 95% CI -0.30 to 0.96). At latest follow-up, there was no effect on alkaline phosphatase (55 weeks) (2 studies, 122 participants, MD -126.11 IU/L, 95% CI -298.5 to 46.27, I2 = 73.4%); serum calcium (6 weeks) (1 study, 40 participants, MD 0.54 mg/dL, 95% CI -0.19 to 1.27); and serum phosphorus (6 weeks) (1 study, 40 participants, MD 0.07 mg/dL, 95% CI -0.22 to 0.36). The certainty of evidence ranged from very low to low. No studies reported on mortality and neurodevelopment outcomes.
Conclusions:
The evidence is insufficient to determine whether enteral supplementation with calcium or phosphorus for preterm or low birth weight infants who are fed mother's own milk or donor human milk is associated with benefit or harm.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Introduction to Electrolytes
Role of Sodium
One...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Chronic Kidney Disease III: Interprofessional Care
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Skeleton and Calcium Homeostasis

